BioCentury
ARTICLE | Company News

Halozyme management update

December 6, 2010 8:00 AM UTC

Halozyme Therapeutics Inc. (NASDAQ:HALO), San Diego, Calif. Business: Endocrine, Cancer, Dermatology Promoted: H. Michael Shepard to CSO from VP of discovery research Resigned: Robert Little as VP and...